Stettler Marianne, Fink Renate, Walker Mirjam, Gottstein Bruno, Geary Timothy G, Rossignol Jean François, Hemphill Andrew
Institute of Parasitology, Faculties of Veterinary Medicine and Medicine, University of Berne, CH-3012 Berne, Switzerland.
Antimicrob Agents Chemother. 2003 Feb;47(2):467-74. doi: 10.1128/AAC.47.2.467-474.2003.
When humans serve as inadvertent intermediate hosts for Echinococcus multilocularis, disease (alveolar echinococcosis [AE]) may result from the expanding parasite metacestode in visceral organs, mostly in the liver. Benzimidazole carbamate derivatives such as mebendazole and albendazole are used for chemotherapeutic treatment of AE. However, these treatments are, in most cases, parasitistatic rather than parasiticidal. As treatment is discontinued, a recurrence of parasite growth has been observed in many AE patients with nonradical resections. The only curative treatment for AE is radical surgical resection of the parasite tissue and support by chemotherapy. As there is a need for new treatment options for AE, the in vitro efficacy of nitazoxanide (NTZ), a broad-spectrum drug used against intestinal parasites and bacteria, was investigated. We showed that in vitro treatment of E. multilocularis metacestodes with NTZ induced high levels of alkaline phosphatase activity in the medium. Concurrently, distinct morphological and ultrastructural alterations were detected. Most significantly, two distinct types of alterations were observed as soon as after 3 h of NTZ treatment. At first, the drug induced a peripheral output of membranous vesicles from the tegumental membrane into the laminated layer. Simultaneously, germinal layer-associated undifferentiated cells produced large vacuoles filled with lipid-like and often electron-dense membranous segments. Other alterations were observed at later time points, including vacuolization of the germinal layer, accumulation of lipid droplets, and lastly, loss of microtriches and separation of the laminated and germinal layers. The pattern of damage induced by NTZ was different from the alterations earlier observed in albendazole sulfoxide-treated vesicles. The nonviability of NTZ-treated metacestodes was confirmed through bioassay, i.e., inoculation of treated and untreated parasites into mice. These experiments demonstrate the in vitro parasiticidal effect of NTZ on E. multilocularis metacestodes.
当人类作为多房棘球绦虫的偶然中间宿主时,疾病(肺泡型棘球蚴病[AE])可能源于内脏器官中不断生长的寄生虫中绦期幼虫,主要是在肝脏。苯并咪唑氨基甲酸酯衍生物如甲苯达唑和阿苯达唑用于AE的化疗。然而,在大多数情况下,这些治疗只是抑制寄生虫生长而非杀灭寄生虫。随着治疗的停止,许多接受非根治性切除的AE患者出现了寄生虫生长复发的情况。AE的唯一根治性治疗方法是根治性手术切除寄生虫组织并辅以化疗。由于需要针对AE的新治疗方案,我们研究了硝唑尼特(NTZ)的体外疗效,NTZ是一种用于治疗肠道寄生虫和细菌的广谱药物。我们发现,用NTZ体外处理多房棘球绦虫中绦期幼虫会导致培养基中碱性磷酸酶活性水平升高。同时,检测到明显的形态和超微结构改变。最显著的是,在NTZ处理3小时后就观察到了两种不同类型的改变。首先,药物诱导膜泡从皮层膜向板层体外周输出。同时,生发层相关的未分化细胞产生充满脂样且通常为电子致密膜段的大液泡。在后期时间点观察到其他改变,包括生发层空泡化、脂滴积累,最后是微毛丧失以及板层体与生发层分离。NTZ诱导的损伤模式与之前在阿苯达唑亚砜处理的囊泡中观察到的改变不同。通过生物测定法,即把处理过和未处理过的寄生虫接种到小鼠体内,证实了经NTZ处理的中绦期幼虫无活力。这些实验证明了NTZ对多房棘球绦虫中绦期幼虫的体外杀寄生虫作用。